Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).

Détails

ID Serval
serval:BIB_7276CBC14AD3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
Périodique
Journal of Clinical Oncology
Auteur(s)
Ruhstaller T., Pless M., Dietrich D., Kranzbuehler H., von Moos R., Moosmann P., Montemurro M., Schneider P.M., Rauch D., Gautschi O., Mingrone W., Widmer L., Inauen R., Brauchli P., Hess V.
ISSN
1527-7755 (Electronic)
ISSN-L
0732-183X
Statut éditorial
Publié
Date de publication
2011
Volume
29
Numéro
6
Pages
626-631
Langue
anglais
Notes
Publication types: Clinical Trial, Phase I ; Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Mots-clé
Adenocarcinoma/drug therapy, Adenocarcinoma/radiotherapy, Aged, Antibodies, Monoclonal/administration & dosage, Antibodies, Monoclonal/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Squamous Cell/drug therapy, Carcinoma, Squamous Cell/radiotherapy, Cisplatin/administration & dosage, Cisplatin/adverse effects, Digestive System Surgical Procedures, Esophageal Neoplasms/drug therapy, Esophageal Neoplasms/radiotherapy, Female, Humans, Male, Maximum Tolerated Dose, Middle Aged, Multicenter Studies as Topic, Neoadjuvant Therapy/methods, Taxoids/administration & dosage, Taxoids/adverse effects
Pubmed
Web of science
Création de la notice
25/10/2011 9:39
Dernière modification de la notice
20/08/2019 15:30
Données d'usage